Total Payments
$18,896
2024 Payments
$16,045
Companies
14
Transactions
54
Medicare Patients
1,023
Medicare Billing
$51,175
Payment Breakdown by Category
Consulting$15,826 (83.8%)
Food & Beverage$3,040 (16.1%)
Gifts$30.00 (0.2%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $15,826 | 16 | 83.8% |
| Food and Beverage | $3,040 | 37 | 16.1% |
| Gift | $30.00 | 1 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| CSL Plasma Inc. | $15,826 | 16 | $0 (2024) |
| Glaukos Corporation | $744.14 | 8 | $0 (2024) |
| Alcon Laboratories Inc | $638.56 | 9 | $0 (2018) |
| Valeant Pharmaceuticals North America LLC | $513.05 | 5 | $0 (2017) |
| Nidek Incorporated | $348.00 | 1 | $0 (2017) |
| Alcon Vision LLC | $166.36 | 3 | $0 (2021) |
| Bausch & Lomb, a division of Bausch Health US, LLC | $161.48 | 3 | $0 (2021) |
| Novartis Pharmaceuticals Corporation | $145.92 | 2 | $0 (2019) |
| Mallinckrodt Hospital Products Inc. | $128.33 | 1 | $0 (2021) |
| Horizon Therapeutics plc | $117.18 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $16,045 | 19 | CSL Plasma Inc. ($15,826) |
| 2023 | $139.91 | 2 | Horizon Therapeutics plc ($117.18) |
| 2022 | $37.83 | 2 | Bausch & Lomb Americas Inc. ($37.83) |
| 2021 | $264.43 | 4 | Mallinckrodt Hospital Products Inc. ($128.33) |
| 2020 | $378.92 | 5 | Glaukos Corporation ($209.06) |
| 2019 | $298.23 | 5 | Novartis Pharmaceuticals Corporation ($145.92) |
| 2018 | $525.72 | 7 | Alcon Laboratories Inc ($408.63) |
| 2017 | $1,206 | 10 | Valeant Pharmaceuticals North America LLC ($513.05) |
All Payment Transactions
54 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | CSL Plasma Inc. | — | Consulting Fee | Cash or cash equivalent | $474.74 | General |
| 11/20/2024 | CSL Plasma Inc. | — | Consulting Fee | Cash or cash equivalent | $477.96 | General |
| 11/06/2024 | CSL Plasma Inc. | — | Consulting Fee | Cash or cash equivalent | $532.24 | General |
| 10/30/2024 | Glaukos Corporation | CE-marked KXLA system (Device) | Food and Beverage | Cash or cash equivalent | $128.32 | General |
| Category: Corneal Health | ||||||
| 10/23/2024 | CSL Plasma Inc. | — | Consulting Fee | Cash or cash equivalent | $535.46 | General |
| 10/16/2024 | CSL Plasma Inc. | — | Consulting Fee | Cash or cash equivalent | $776.98 | General |
| 09/25/2024 | CSL Plasma Inc. | — | Consulting Fee | Cash or cash equivalent | $1,151.46 | General |
| 09/18/2024 | CSL Plasma Inc. | — | Consulting Fee | Cash or cash equivalent | $1,121.98 | General |
| 08/23/2024 | Glaukos Corporation | CE-marked KXLA system (Device) | Food and Beverage | Cash or cash equivalent | $34.24 | General |
| Category: Corneal Health | ||||||
| 08/21/2024 | CSL Plasma Inc. | — | Consulting Fee | Cash or cash equivalent | $1,179.48 | General |
| 08/07/2024 | CSL Plasma Inc. | — | Consulting Fee | Cash or cash equivalent | $1,294.48 | General |
| 07/17/2024 | CSL Plasma Inc. | — | Consulting Fee | Cash or cash equivalent | $1,236.98 | General |
| 07/10/2024 | CSL Plasma Inc. | — | Consulting Fee | Cash or cash equivalent | $1,236.98 | General |
| 07/01/2024 | CSL Plasma Inc. | — | Consulting Fee | Cash or cash equivalent | $1,236.98 | General |
| 05/22/2024 | CSL Plasma Inc. | — | Consulting Fee | Cash or cash equivalent | $1,185.64 | General |
| 05/08/2024 | CSL Plasma Inc. | — | Consulting Fee | Cash or cash equivalent | $1,070.64 | General |
| 04/17/2024 | CSL Plasma Inc. | — | Consulting Fee | Cash or cash equivalent | $1,185.64 | General |
| 04/17/2024 | CSL Plasma Inc. | — | Consulting Fee | Cash or cash equivalent | $1,128.14 | General |
| 02/02/2024 | Glaukos Corporation | CE-marked KXLA system (Device) | Food and Beverage | Cash or cash equivalent | $56.30 | General |
| Category: Corneal Health | ||||||
| 06/26/2023 | Rayner Intraocular Lenses Limited | Omidria (Drug), RayOne EMV, RayOne Spheric | Food and Beverage | Cash or cash equivalent | $22.73 | General |
| Category: Ophthalmology | ||||||
| 03/28/2023 | Horizon Therapeutics plc | TEPEZZA (Drug) | Food and Beverage | In-kind items and services | $117.18 | General |
| Category: TEPEZZA | ||||||
| 10/07/2022 | Bausch & Lomb Americas Inc. | XIPERE (Drug), VYZULTA, LOTEMAX SM | Food and Beverage | In-kind items and services | $13.68 | General |
| Category: Ophthalmology | ||||||
| 05/11/2022 | Bausch & Lomb Americas Inc. | XIPERE (Drug), VYZULTA, PROLENSA | Food and Beverage | In-kind items and services | $24.15 | General |
| Category: Ophthalmology | ||||||
| 10/20/2021 | Alcon Vision LLC | Clareon (Device) | Food and Beverage | In-kind items and services | $94.40 | General |
| Category: Ophthalmology | ||||||
| 07/14/2021 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $128.33 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 202 | 248 | $59,014 | $11,069 |
| 2022 | 6 | 241 | 287 | $67,750 | $13,633 |
| 2021 | 7 | 266 | 313 | $70,330 | $12,253 |
| 2020 | 6 | 314 | 371 | $76,597 | $14,220 |
Total Patients
1,023
Total Services
1,219
Medicare Billing
$51,175
Procedure Codes
26
All Medicare Procedures & Services
26 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 67 | 77 | $27,412 | $5,310 | 19.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 38 | 63 | $15,813 | $2,981 | 18.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 11 | 11 | $5,115 | $1,085 | 21.2% |
| 92083 | Exam of visual field with extended testing | Facility | 2023 | 35 | 41 | $5,235 | $749.39 | 14.3% |
| 92133 | Imaging of optic nerve | Facility | 2023 | 25 | 30 | $2,610 | $474.38 | 18.2% |
| 92136 | Measurement of corneal curvature and depth of eye | Facility | 2023 | 11 | 11 | $1,339 | $236.50 | 17.7% |
| 92134 | Imaging of retina | Facility | 2023 | 15 | 15 | $1,490 | $233.16 | 15.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 74 | 88 | $31,328 | $6,175 | 19.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 52 | 72 | $18,072 | $3,539 | 19.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 22 | 22 | $10,230 | $2,001 | 19.6% |
| 92083 | Exam of visual field with extended testing | Facility | 2022 | 42 | 48 | $3,888 | $910.48 | 23.4% |
| 92133 | Imaging of optic nerve | Facility | 2022 | 31 | 34 | $2,494 | $550.70 | 22.1% |
| 92134 | Imaging of retina | Facility | 2022 | 20 | 23 | $1,738 | $456.34 | 26.3% |
| 92014 | Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits | Facility | 2021 | 76 | 95 | $32,144 | $5,305 | 16.5% |
| 92012 | Eye and medical examination for diagnosis and treatment, established patient | Facility | 2021 | 53 | 69 | $16,489 | $2,528 | 15.3% |
| 92004 | Eye and medical examination for diagnosis and treatment, new patient, 1 or more visits | Facility | 2021 | 31 | 31 | $12,462 | $2,183 | 17.5% |
| 92083 | Measurement of field of vision during daylight conditions, extended examination | Facility | 2021 | 49 | 55 | $4,410 | $1,085 | 24.6% |
| 92134 | Diagnostic imaging of retina | Facility | 2021 | 18 | 23 | $1,800 | $445.94 | 24.8% |
| 92133 | Diagnostic imaging of optic nerve of eye | Facility | 2021 | 26 | 27 | $1,946 | $414.17 | 21.3% |
| 92136 | Measurement of corneal curvature and depth of eye | Facility | 2021 | 13 | 13 | $1,079 | $292.68 | 27.1% |
| 92014 | Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits | Facility | 2020 | 93 | 105 | $32,655 | $6,348 | 19.4% |
| 92012 | Eye and medical examination for diagnosis and treatment, established patient | Facility | 2020 | 63 | 96 | $20,544 | $3,479 | 16.9% |
| 92004 | Eye and medical examination for diagnosis and treatment, new patient, 1 or more visits | Facility | 2020 | 32 | 32 | $11,936 | $1,956 | 16.4% |
| 92083 | Measurement of field of vision during daylight conditions | Facility | 2020 | 58 | 64 | $5,184 | $1,238 | 23.9% |
| 92133 | Diagnostic imaging of optic nerve of eye | Facility | 2020 | 48 | 51 | $4,581 | $837.46 | 18.3% |
About Dr. Peter Kastl, MD
Dr. Peter Kastl, MD is a Ophthalmology healthcare provider based in New Orleans, Louisiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/23/2006. The National Provider Identifier (NPI) number assigned to this provider is 1467568055.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Peter Kastl, MD has received a total of $18,896 in payments from pharmaceutical and medical device companies, with $16,045 received in 2024. These payments were reported across 54 transactions from 14 companies. The most common payment nature is "Consulting Fee" ($15,826).
As a Medicare-enrolled provider, Kastl has provided services to 1,023 Medicare beneficiaries, totaling 1,219 services with total Medicare billing of $51,175. Data is available for 4 years (2020–2023), covering 26 distinct procedure/service records.
Ad
Practice Information
- Specialty Ophthalmology
- Location New Orleans, LA
- Active Since 08/23/2006
- Last Updated 04/20/2017
- Taxonomy Code 207W00000X
- Entity Type Individual
- NPI Number 1467568055
Products in Payments
- CyPass (Device) $329.16
- LATANOPROSTENE BUNOD (Drug) $248.18
- ISTENT TRABECULAR MICRO-BYPASS STENT SYSTEM (Device) $232.28
- CE-marked KXLA system (Device) $218.86
- Centurion (Device) $184.36
- iStent inject Trabecular Micro-Bypass Stent System (Device) $168.29
- DUREZOL (Drug) $145.92
- AcrySof (Device) $144.84
- ACTHAR (Biological) $128.33
- Photrexa (Device) $124.71
- ENVISTA (Device) $123.37
- TEPEZZA (Drug) $117.18
- LOTEMAX GEL (Drug) $105.98
- PROLENSA (Drug) $96.25
- Clareon (Device) $94.40
- SOFPORT AO (Device) $62.64
- ReSTOR (Device) $52.16
- XIPERE (Drug) $37.83
- Omidria (Drug) $22.73
- VYZULTA (Drug) $21.90
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Ophthalmology Doctors in New Orleans
Donald Mazzulla, Md, MD
Ophthalmology — Payments: $211,127
Ophthalmology $211,127
Pulin Shah, Md, MD
Ophthalmology — Payments: $201,632
Ophthalmology $201,632
Dr. Rebecca Metzinger, Md, MD
Ophthalmology — Payments: $63,634
Ophthalmology $63,634
Lena Al-Dujaili
Ophthalmology — Payments: $46,197
Ophthalmology $46,197
Jayne Weiss, Md, MD
Ophthalmology — Payments: $45,530
Ophthalmology $45,530
Ze Zhang, Md, MD
Ophthalmology — Payments: $39,081
Ophthalmology $39,081